Smofkabiven Peripheral 38 mg

SMOFKABIVEN Peripheral 38 mg is an intravenous emulsion containing magnesium sulfate. It is designed to support nutritional needs and electrolyte balance in clinical settings. This product is manufactured by Fresenius Kabi Canada Ltd.

SMOFKABIVEN Peripheral 38 mg is primarily used for nutritional support and electrolyte replenishment. It contains magnesium sulfate, which is essential for various bodily functions, including muscle and nerve function, blood glucose control, and blood pressure regulation. This emulsion is often administered intravenously to patients who require nutritional support due to inadequate oral intake or absorption issues.

The effects of SMOFKABIVEN Peripheral 38 mg are generally related to its nutritional and electrolyte-replenishing properties. Patients may experience improved muscle function and overall well-being when used as directed. However, individual responses can vary, and it is important to follow medical guidance for optimal results.

SMOFKABIVEN Peripheral 38 mg should be handled with care and administered under medical supervision. It is important to check for any allergies or sensitivities to magnesium sulfate or any other components in the emulsion. Proper storage and handling are crucial to maintain the integrity and effectiveness of the product.

SMOFKABIVEN Peripheral 38 mg may interact with certain medications or supplements. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol and other substances that affect electrolyte balance should be used with caution.